MASL1: A neglected ROCO protein

Biochemical Society Transactions

Volumn 40, Issue 5, 2012, Pages 1090-1094

  Dihanich, Sybille ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Leucine rich repeat kinase 2 (LRRK2); Malignant fibrous histiocytoma amplified sequences with leucine rich tandem repeats 1 (MASL1); Parkinson's disease; ROCO protein

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LEUCINE RICH REPEAT KINASE 2; MALIGNANT FIBROUS HISTIOCYTOMA AMPLIFIED SEQUENCES WITH LEUCINE-RICH TANDEM REPEATS 1; ONCOPROTEIN; PROTEIN; PROTEIN ROCO; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; CHLOROBIUM; CHROMOSOME 8; CROHN DISEASE; DIMERIZATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE AMPLIFICATION; MALIGNANT FIBROUS HISTIOCYTOMA; MUTATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY;

CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS; ONCOGENE PROTEINS; PARKINSON DISEASE;

EID: 84866716156     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120127     Document Type: Review

References (38)

1. Ozzello, L., Stout, A.P. and Murray, M.R. (1963) Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 16, 331-344
2. Erlandson, R.A. and Antonescu, C.R. (2004) The rise and fall of malignant fibrous histiocytoma. Ultrastruct. Pathol. 28, 283-289
3. Enzinger, F.M. (1986) Malignant fibrous histiocytoma 20 years after Stout. Am. J. Surg. Pathol. 10 (Suppl. 1), 43-53
4. Fletcher, C.D. (2006) The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48, 3-12
5. Dei Tos, A.P. (2006) Classification of pleomorphic sarcomas: where are we now? Histopathology 48, 51-62
6. Sakabe, T., Shinomiya, T., Mori, T., Ariyama, Y., Fukuda, Y., Fujiwara, T., Nakamura, Y. and Inazawa, J. (1999) Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization. Cancer Res. 59, 511-515
7. Marín, I., van Egmond, W.N. and van Haastert, P.J. (2008) The Roco protein family: a functional perspective. FASEB J. 22, 3103-3110
8. Bosgraaf, L. and Van Haastert, P.J. (2003) Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta 1643, 5-10
9. Paisán-Ruíz, C., Jain, S., Evans, E.W., Gilks, W.P., Simón, J., van der Brug, M., López de Munain, A., Aparicio, S., Gil, A.M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600
10. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607
11. Kissil, J.L., Feinstein, E., Cohen, O., Jones, P.A., Tsai, Y.C., Knowles, M.A., Eydmann, M.E. and Kimchi, A. (1997) DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 15, 403-407
12. Randall, R.L., Albritton, K.H., Ferney, B.J. and Layfield, L. (2004) Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis. Am. J. Orthop. 33, 602-608
13. Mertens, F., Strömberg, U., Mandahl, N., Dal Cin, P., De Wever, I., Fletcher, C.D., Mitelman, F., Rosai, J., Rydholm, A., Sciot, R. et al. (2002) Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. Cancer Res. 62, 3980-3984
14. Tagawa, H., Karnan, S., Kasugai, Y., Tuzuki, S., Suzuki, R., Hosokawa, Y. and Seto, M. (2004) MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8. Oncogene 23, 2576-2581
15. Sakakura, C., Mori, T., Sakabe, T., Ariyama, Y., Shinomiya, T., Date, K., Hagiwara, A., Yamaguchi, T., Takahashi, T., Nakamura, Y. et al. (1999) Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 24, 299-305
16. Moskaluk, C.A., Hu, J. and Perlman, E.J. (1998) Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosomes Cancer 22, 305-311
17. Claeys, I., Holvoet, M., Eyskens, B., Adriaensens, P., Gewillig, M., Fryns, J.P. and Devriendt, K. (1997) A recognisable behavioural phenotype associated with terminal deletions of the short arm of chromosome 8. Am. J. Med. Genet. 74, 515-520
18. Ballarati, L., Cereda, A., Caselli, R., Selicorni, A., Recalcati, M.P., Maitz, S., Finelli, P., Larizza, L. and Giardino, D. (2011) Genotype-phenotype correlations in a new case of 8p23.1 deletion and review of the literature. Eur. J. Med. Genet. 54, 55-59
19. Devriendt, K., Matthijs, G., Van Dael, R., Gewillig, M., Eyskens, B., Hjalgrim, H., Dolmer, B., McGaughran, J., Bröndum-Nielsen, K., Marynen, P. et al. (1999) Delineation of the critical deletion region for congenital heart defects, on chromosome 8p23.1. Am. J. Hum. Genet. 64, 1119-1126
20. Chien, W.H., Gau, S.S., Wu, Y.Y., Huang, Y.S., Fang, J.S., Chen, Y.J., Soong, W.T., Chiu, Y.N. and Chen, C.H. (2010) Identification and molecular characterization of two novel chromosomal deletions associated with autism. Clin. Genet. 78, 449-456
21. Allen, N.M., O'hici, B., Anderson, G., Nestor, T., Lynch, S.A. and King, M. (2011) Variant late-infantile neuronal ceroid lipofuscinosis due to a novel heterozygous CLN8 mutation and de novo 8p23.3 deletion. Clin. Genet. 81, 602-604
22. Baynam, G., Goldblatt, J. and Walpole, I. (2008) Deletion of 8p23.1 with features of Cornelia de Lange syndrome and congenital diaphragmatic hernia and a review of deletions of 8p23.1 to 8pter? A further locus for Cornelia de Lange syndrome. Am. J. Med. Genet., Part A 146A, 1565-1570
23. Dizier, M.H., Quesneville, H., Besse-Schmittler, C., Guilloud-Bataille, M., Selinger-Leneman, H., Clerget-Darpoux, F. and Demenais, F. (2003) Indication of linkage and genetic heterogeneity for asthma and atopy on chromosomes 8p and 12q in 107 French EGEA families. Eur. J. Hum. Genet. 11, 590-596
24. Kim, S.H., Ma, X., Weremowicz, S., Ercolino, T., Powers, C., Mlynarski, W., Bashan, K.A., Warram, J.H., Mychaleckyj, J., Rich, S.S. et al. (2004) Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. Diabetes 53, 1375-1384
25. Reference deleted
26. Hollox, E.J., Huffmeier, U., Zeeuwen, P.L., Palla, R., Lascorz, J., Rodijk-Olthuis, D., van de Kerkhof, P.C., Traupe, H., de Jongh, G., den Heijer, M. et al. (2008) Psoriasis is associated with increased β-defensin genomic copy number. Nat. Genet. 40, 23-25
27. Fellermann, K., Stange, D.E., Schaeffeler, E., Schmalzl, H., Wehkamp, J., Bevins, C.L., Reinisch, W., Teml, A., Schwab, M., Lichter, P. et al. (2006) A chromosome 8 gene-cluster polymorphism with low human β-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 79, 439-448
28. Ng, A.C., Eisenberg, J.M., Heath, R.J., Huett, A., Robinson, C.M., Nau, G.J. and Xavier, R.J. (2010) Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunity. Proc. Natl. Acad. Sci. U.S.A. 108 (Suppl. 1), 4631-4638
29. Lewis, P.A. (2009) The function of ROCO proteins in health and disease. Biol. Cell 101, 183-191
30. Van Limbergen, J., Wilson, D.C. and Satsangi, J. (2009) The genetics of Crohn's disease. Annu. Rev. Genomics Hum. Genet. 10, 89-116
31. Carlessi, R., Levin-Salomon, V., Ciprut, S., Bialik, S., Berissi, H., Albeck, S., Peleg, Y. and Kimchi, A. (2011) GTP binding to the ROC domain of DAP-kinase regulates its function through intramolecular signalling. EMBO Rep. 12, 917-923
32. Lewis, P.A., Greggio, E., Beilina, A., Jain, S., Baker, A. and Cookson, M.R. (2007) The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem. Biophys. Res. Commun. 357, 668-671
33. Greggio, E., Taymans, J.-M., Zhen, E.Y., Ryder, J., Vancraenenbroeck, R., Beilina, A., Sun, P., Deng, J., Jaffe, H., Baekelandt, V. et al. (2009) The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites. Biochem. Biophys. Res. Commun. 389, 449-454
34. Piccoli, G., Condliffe, S.B., Bauer, M., Giesert, F., Boldt, K., De Astis, S., Meixner, A., Sarioglu, H., Vogt-Weisenhorn, D.M. and Wurst, W. (2011) LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J. Neurosci. 31, 2225-2237
35. Maiuri, M.C., Tasdemir, E., Criollo, A., Morselli, E., Vicencio, J.M., Carnuccio, R. and Kroemer, G. (2008) Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 16, 87-93
36. Moehle, M.S., Webber, P.J., Tse, T., Sukar, N., Standaert, D.G., DeSilva, T.M., Cowell, R.M. and West, A.B. (2012) LRRK2 inhibition attenuates microglial inflammatory responses. J. Neurosci. 32, 1602-1611
37. Gotthardt, K., Weyand, M., Kortholt, A., Van Haastert, P.J. and Wittinghofer, A. (2008) Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. EMBO J. 27, 2239-2249
38. Li, Y., Dunn, L., Greggio, E., Krumm, B., Jackson, G.S., Cookson, M.R., Lewis, P.A. and Deng, J. (2009) The R1441C mutation alters the folding properties of the ROC domain of LRRK2. Biochim. Biophys. Acta 1792, 1194-1197